Jacobio Pharmaceuticals Overview

  • Founded
  • 2015
Founded
  • Status
  • IPO Registration
  • Employees
  • 130
Employees
  • Latest Deal Type
  • IPO
  • (Announced)
  • Latest Deal Amount
  • $400M
Latest Deal Amount
  • Investors
  • 7

Jacobio Pharmaceuticals General Information

Description

Developer of pharmaceuticals intended to treat malignant tumor and sepsis. The company has set up analysis room, preparation room, synthesis room, pharmacology department, medical department and other departments to provide patients with antibody new drugs, small molecule oral anti-tumor drugs and other products, enabling patients to obtain new treatment options.

Contact Information

Ownership Status
In IPO Registration
Financing Status
Venture Capital-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Primary Office
  • F2 Floor, Biomedical Park
  • No. 88 Kechuang 6th Street, Economic Development Zone
  • Beijing
  • China
+86 010 0000 0000

Jacobio Pharmaceuticals Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Jacobio Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. IPO 06-Aug-2020 $400M 00000 Announced Generating Revenue
4. Later Stage VC (Series C1) 01-Feb-2020 0000 00000 Completed Generating Revenue
3. Later Stage VC (Series C) 30-Aug-2018 0000 0000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Oct-2017 $20M $20M 0000 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Oct-2016 Completed Startup
To view Jacobio Pharmaceuticals’s complete valuation and funding history, request access »

Jacobio Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of pharmaceuticals intended to treat malignant tumor and sepsis. The company has set up analysis room, prepara
Pharmaceuticals
Beijing, China
130 As of 2020
00000
00000000 00000

0000000

tate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proide
0000 000000000
London, United Kingdom
0000
0000 0000-00-00
0000000000 0 0000

0000000

rcitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehen
0000 000000000
Turku, Finland
00 As of 0000
0000
00.00 0000-00-00
0000000000 0 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Jacobio Pharmaceuticals Competitors (34)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Istesso Venture Capital-Backed London, United Kingdom 0000 0000000000 0 0000
0000000 000000 Venture Capital-Backed Turku, Finland 00 0000 0000000000 0 0000
0000000 0000000000 Formerly VC-backed Cambridge, MA 000 00.00 00000000 00.00
00 000000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
00000000000 Angel-Backed Culver City, CA 00000 000000000000 00000
You’re viewing 5 of 34 competitors. Get the full list »

Jacobio Pharmaceuticals Executive Team (2)

Name Title Board Seat Contact Info
Yinxiang Wang Ph.D Chief Executive Officer, Co-Founder & Chairman
Shaojing Hu President
To view Jacobio Pharmaceuticals’s complete executive team members history, request access »

Jacobio Pharmaceuticals Board Members (3)

Name Representing Role Since
Amy Tang Qiming Venture Partners Board Member 000 0000
Nisa Leung Qiming Venture Partners Board Member 000 0000
Yinxiang Wang Ph.D Jacobio Pharmaceuticals Chief Executive Officer, Co-Founder & Chairman 000 0000
To view Jacobio Pharmaceuticals’s complete board members history, request access »

Jacobio Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Jacobio Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CICC Capital PE/Buyout Minority 000 0000 000000 0
Shiyu Capital Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
Prudence Investment Management Hedge Fund Minority 000 0000 000000 0
Lilly Asia Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »